Bioncotech Therapeutics is a biopharmaceutical company focused on the development of a new agent in immuno-oncology. Following approval from the AEMPS to start the clinical development for BO-112, the company began trials in June 2016.
HAVE A PROJECT IN MIND?
Entrepreneurship is in everything we do. Come tour our creative space and discover how to bring your ideas to life at IE.